$CWBC
Community West Bancshares Stock $cwbc

$cwbc Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000112737121000128 Filed on August 04, 2021

Income Statement

Concept	2021 Q2	2020 Q2	2020 Q1
Revenue	$18.36M	$15.98M	$16.51M
YoY Change	14.83%	-4.74%	1.33%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.200M	$1.410M	$1.180M
YoY Change	56.03%	-18.97%	-36.56%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$274.0K	$410.0K	$477.0K
YoY Change	-33.17%	-50.84%	5.07%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$10.03M	$3.121M	$9.117M
YoY Change	221.31%	-63.16%	27.17%
Income Tax	$2.465M	$820.0K	$2.494M
% Of Pretax Income	24.58%	26.27%	27.36%
Net Earnings	$7.563M	$2.301M	$6.623M
YoY Change	228.68%	-62.2%	26.97%
Net Earnings / Revenue	41.2%	14.4%	40.12%
Basic Earnings Per Share	$0.61	$0.18	$0.52
Diluted Earnings Per Share	$0.60	$0.18	$0.52
COMMON SHARES
Basic Shares Outstanding	12.50M shares	12.45M shares	12.73M shares
Diluted Shares Outstanding	12.55M shares	12.49M shares	12.78M shares

Balance Sheet

Concept	2021 Q2	2020 Q2	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$120.7M	$118.6M	$36.16M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$8.465M	$7.257M	$7.410M
YoY Change	16.65%	-6.26%	-8.47%
Goodwill	$53.78M	$53.78M	$53.78M
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$2.281B	$1.914B	$1.619B
YoY Change	19.17%	18.63%	3.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$45.30M	$30.50M	$44.20M
YoY Change	48.52%	7.77%	37.69%
Accrued Expenses		$5.900M	$6.100M
YoY Change		-13.24%	-24.69%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$45.30M	$30.50M	$44.20M
YoY Change	48.52%	7.77%	37.69%
LONG-TERM LIABILITIES
Long-Term Debt	$5.200M	$5.200M	$5.200M
YoY Change	0.0%	0.0%	0.0%
Other Long-Term Liabilities	$13.00M	$10.60M	$9.300M
YoY Change	22.64%	8.16%	-10.58%
Total Long-Term Liabilities	$5.200M	$5.200M	$5.200M
YoY Change	0.0%	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$45.30M	$30.50M	$44.20M
Total Long-Term Liabilities	$5.200M	$5.200M	$5.200M
Total Liabilities	$2.030B	$1.685B	$1.400B
YoY Change	20.43%	21.98%	4.73%
SHAREHOLDERS EQUITY
Retained Earnings	$162.9M	$142.1M	$141.1M
YoY Change	14.66%	10.37%	13.7%
Common Stock	$75.27M	$79.06M	$78.85M
YoY Change	-4.8%	-19.5%	-22.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$251.0M	$228.6M	$218.7M
YoY Change
Total Liabilities & Shareholders Equity	$2.281B	$1.914B	$1.619B
YoY Change	19.17%	18.63%	3.48%

Cashflow Statement

Concept	2021 Q2	2020 Q2	2020 Q1
OPERATING ACTIVITIES
Net Income	$7.563M	$2.301M	$6.623M
YoY Change	228.68%	-62.2%	26.97%
Depreciation, Depletion And Amortization	$2.200M	$1.410M	$1.180M
YoY Change	56.03%	-18.97%	-36.56%
Cash From Operating Activities	$21.40M	-$4.160M	$5.931M
YoY Change	-614.42%	-249.64%	-14.07%
INVESTING ACTIVITIES
Capital Expenditures	-$360.0K	-$70.00K	$32.00K
YoY Change	414.29%	-58.82%	-75.94%
Acquisitions
YoY Change
Other Investing Activities	-$165.8M	-$211.1M	-$27.42M
YoY Change	-21.43%	629.77%	162.14%
Cash From Investing Activities	-$166.2M	-$211.1M	-$27.45M
YoY Change	-21.29%	625.75%	159.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$11.05M
YoY Change			489.75%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	50.61M	297.7M	$5.111M
YoY Change	-83.0%	597.45%	21.84%
NET CHANGE
Cash From Operating Activities	21.40M	-4.160M	$5.931M
Cash From Investing Activities	-166.2M	-211.1M	-$27.45M
Cash From Financing Activities	50.61M	297.7M	$5.111M
Net Change In Cash	-94.17M	82.39M	-$16.41M
YoY Change	-214.3%	403.3%	-3330.71%
FREE CASH FLOW
Cash From Operating Activities	$21.40M	-$4.160M	$5.931M
Capital Expenditures	-$360.0K	-$70.00K	$32.00K
Free Cash Flow	$21.76M	-$4.090M	$5.899M
YoY Change	-632.03%	-238.64%	-12.85%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001127371
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	10439000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	12915000	USD
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12524609	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12509848	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12329089	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12509848	shares
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2021Q2	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
CY2020Q2	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-31977
	dei	Entity Registrant Name EntityRegistrantName	CENTRAL VALLEY COMMUNITY BANCORP
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CA
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0539125
	dei	Entity Address Address Line1 EntityAddressAddressLine1	7100 N. Financial Dr., Suite 101
	dei	Entity Address City Or Town EntityAddressCityOrTown	Fresno
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	93720
	dei	City Area Code CityAreaCode	559
	dei	Local Phone Number LocalPhoneNumber	298-1775
	dei	Security12b Title Security12bTitle	Common Stock, no par value
	dei	Trading Symbol TradingSymbol	CVCY
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	11984214	shares
CY2021Q2	us-gaap	Cash And Due From Banks CashAndDueFromBanks	39346000	USD
CY2020Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	34175000	USD
CY2021Q2	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	81320000	USD
CY2020Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	36103000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	120666000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	70278000	USD
CY2021Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	952416000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	710092000	USD
CY2021Q2	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	7522000	USD
CY2020Q4	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	7634000	USD
CY2021Q2	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1059506000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1089432000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8465000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8228000	USD
CY2021Q2	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	39062000	USD
CY2020Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	28713000	USD
CY2021Q2	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	5595000	USD
CY2020Q4	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	5595000	USD
CY2021Q2	us-gaap	Goodwill Goodwill	53777000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	53777000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	835000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1183000	USD
CY2021Q2	cvcy	Accrued Interest Receivable And Other Assets AccruedInterestReceivableAndOtherAssets	32706000	USD
CY2020Q4	cvcy	Accrued Interest Receivable And Other Assets AccruedInterestReceivableAndOtherAssets	29164000	USD
CY2021Q2	us-gaap	Assets Assets	2280550000	USD
CY2020Q4	us-gaap	Assets Assets	2004096000	USD
CY2021Q2	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	899406000	USD
CY2020Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	824889000	USD
CY2021Q2	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	1079688000	USD
CY2020Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	897821000	USD
CY2021Q2	us-gaap	Deposits Deposits	1979094000	USD
CY2020Q4	us-gaap	Deposits Deposits	1722710000	USD
CY2021Q2	us-gaap	Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust	5155000	USD
CY2020Q4	us-gaap	Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust	5155000	USD
CY2021Q2	cvcy	Accrued Interest Payable And Other Liabilities AccruedInterestPayableAndOtherLiabilities	45252000	USD
CY2020Q4	cvcy	Accrued Interest Payable And Other Liabilities AccruedInterestPayableAndOtherLiabilities	31210000	USD
CY2021Q2	us-gaap	Liabilities Liabilities	2029501000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	1759075000	USD
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	75265000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	79416000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	162910000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	150749000	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	12874000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	14856000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	251049000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	245021000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2280550000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2004096000	USD
CY2021Q2	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	13556000	USD
CY2020Q2	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	12600000	USD
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	27321000	USD
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	25498000	USD
CY2021Q2	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	29000	USD
CY2020Q2	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	13000	USD
	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	61000	USD
	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	196000	USD
CY2021Q2	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	3361000	USD
CY2020Q2	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	2959000	USD
	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	6094000	USD
	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	6225000	USD
CY2021Q2	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	1409000	USD
CY2020Q2	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	412000	USD
CY2021Q2	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	252000	USD
CY2020Q2	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	374000	USD
	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	520000	USD
	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	2726000	USD
	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	571000	USD
CY2021Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	18355000	USD
CY2020Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	15984000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	36202000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	32490000	USD
	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	806000	USD
CY2021Q2	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	22000	USD
CY2020Q2	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	36000	USD
	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	46000	USD
	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	81000	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	274000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	410000	USD
	us-gaap	Interest Expense InterestExpense	566000	USD
	us-gaap	Interest Expense InterestExpense	887000	USD
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	18081000	USD
CY2020Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	15574000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	35636000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	31603000	USD
CY2021Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-1500000	USD
CY2020Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	3000000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-3300000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	4375000	USD
CY2021Q2	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	19581000	USD
CY2020Q2	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	12574000	USD
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	38936000	USD
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	27228000	USD
CY2021Q2	cvcy	Service Charges ServiceCharges	467000	USD
CY2020Q2	cvcy	Service Charges ServiceCharges	447000	USD
	cvcy	Service Charges ServiceCharges	899000	USD
	cvcy	Service Charges ServiceCharges	1093000	USD
CY2021Q2	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	176000	USD
CY2020Q2	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	176000	USD
	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	349000	USD
	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	358000	USD
CY2021Q2	cvcy	Interchange Fees InterchangeFees	471000	USD
CY2020Q2	cvcy	Interchange Fees InterchangeFees	307000	USD
	cvcy	Interchange Fees InterchangeFees	841000	USD
	cvcy	Interchange Fees InterchangeFees	640000	USD
CY2021Q2	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-79000	USD
CY2020Q2	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-58000	USD
	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-79000	USD
	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	4140000	USD
CY2021Q2	cvcy	Dividends Federal Home Loan Bank Stocks DividendsFederalHomeLoanBankStocks	83000	USD
CY2020Q2	cvcy	Dividends Federal Home Loan Bank Stocks DividendsFederalHomeLoanBankStocks	75000	USD
	cvcy	Dividends Federal Home Loan Bank Stocks DividendsFederalHomeLoanBankStocks	153000	USD
	cvcy	Dividends Federal Home Loan Bank Stocks DividendsFederalHomeLoanBankStocks	182000	USD
CY2021Q2	cvcy	Loan Placement Fees LoanPlacementFees	510000	USD
CY2020Q2	cvcy	Loan Placement Fees LoanPlacementFees	561000	USD
	cvcy	Loan Placement Fees LoanPlacementFees	1167000	USD
	cvcy	Loan Placement Fees LoanPlacementFees	860000	USD
CY2021Q2	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	449000	USD
CY2020Q2	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	537000	USD
	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	746000	USD
	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	1315000	USD
CY2021Q2	us-gaap	Noninterest Income NoninterestIncome	2077000	USD
CY2020Q2	us-gaap	Noninterest Income NoninterestIncome	2045000	USD
	us-gaap	Noninterest Income NoninterestIncome	4076000	USD
	us-gaap	Noninterest Income NoninterestIncome	8588000	USD
CY2021Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6979000	USD
CY2020Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6812000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	13917000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	14324000	USD
CY2021Q2	us-gaap	Occupancy Net OccupancyNet	1201000	USD
CY2020Q2	us-gaap	Occupancy Net OccupancyNet	1139000	USD
	us-gaap	Occupancy Net OccupancyNet	2314000	USD
	us-gaap	Occupancy Net OccupancyNet	2283000	USD
CY2021Q2	us-gaap	Professional Fees ProfessionalFees	475000	USD
CY2020Q2	us-gaap	Professional Fees ProfessionalFees	522000	USD
	us-gaap	Professional Fees ProfessionalFees	831000	USD
	us-gaap	Professional Fees ProfessionalFees	980000	USD
CY2021Q2	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	625000	USD
CY2020Q2	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	554000	USD
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	1242000	USD
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	890000	USD
CY2021Q2	cvcy	Regulatory Assessments RegulatoryAssessments	172000	USD
CY2020Q2	cvcy	Regulatory Assessments RegulatoryAssessments	146000	USD
	cvcy	Regulatory Assessments RegulatoryAssessments	333000	USD
	cvcy	Regulatory Assessments RegulatoryAssessments	193000	USD
CY2021Q2	cvcy	At Mand Debit Card Expenses ATMandDebitCardExpenses	191000	USD
CY2020Q2	cvcy	At Mand Debit Card Expenses ATMandDebitCardExpenses	187000	USD
	cvcy	At Mand Debit Card Expenses ATMandDebitCardExpenses	416000	USD
	cvcy	At Mand Debit Card Expenses ATMandDebitCardExpenses	481000	USD
CY2021Q2	cvcy	Information Technology InformationTechnology	611000	USD
CY2020Q2	cvcy	Information Technology InformationTechnology	602000	USD
	cvcy	Information Technology InformationTechnology	1170000	USD
	cvcy	Information Technology InformationTechnology	1210000	USD
CY2021Q2	cvcy	Directors Expenses DirectorsExpenses	113000	USD
CY2020Q2	cvcy	Directors Expenses DirectorsExpenses	136000	USD
	cvcy	Directors Expenses DirectorsExpenses	154000	USD
	cvcy	Directors Expenses DirectorsExpenses	328000	USD
CY2021Q2	us-gaap	Advertising Expense AdvertisingExpense	128000	USD
CY2020Q2	us-gaap	Advertising Expense AdvertisingExpense	167000	USD
	us-gaap	Advertising Expense AdvertisingExpense	257000	USD
	us-gaap	Advertising Expense AdvertisingExpense	340000	USD
CY2021Q2	cvcy	Internet Banking Expense InternetBankingExpense	84000	USD
CY2020Q2	cvcy	Internet Banking Expense InternetBankingExpense	182000	USD
	cvcy	Internet Banking Expense InternetBankingExpense	208000	USD
	cvcy	Internet Banking Expense InternetBankingExpense	378000	USD
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	173000	USD
CY2020Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	173000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	347000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	347000	USD
CY2021Q2	us-gaap	Other Noninterest Expense OtherNoninterestExpense	878000	USD
CY2020Q2	us-gaap	Other Noninterest Expense OtherNoninterestExpense	878000	USD
	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1829000	USD
	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1823000	USD
CY2021Q2	us-gaap	Noninterest Expense NoninterestExpense	11630000	USD
CY2020Q2	us-gaap	Noninterest Expense NoninterestExpense	11498000	USD
	us-gaap	Noninterest Expense NoninterestExpense	23018000	USD
	us-gaap	Noninterest Expense NoninterestExpense	23577000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	10028000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3121000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	19994000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	12239000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2465000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	820000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4952000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3315000	USD
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7563000	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2301000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	15042000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8924000	USD
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.61
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.71
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12498809	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12449283	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12497217	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12592126	shares
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.60
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12548044	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12486681	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12548101	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12646403	shares
CY2021Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.12
CY2020Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.11
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.23
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.22
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	7563000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	2301000	USD
	us-gaap	Net Income Loss NetIncomeLoss	15042000	USD
	us-gaap	Net Income Loss NetIncomeLoss	8924000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	10729000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	12366000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-2892000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	10808000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	12424000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	10679000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-79000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-58000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-79000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	4140000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-2813000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	6539000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	3196000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	3673000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-831000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1933000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	7612000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8751000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1982000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4606000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	15175000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11052000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	13060000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	13530000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	218673000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	2301000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	8751000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	58000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	128000	USD
CY2020Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1372000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	19000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	228558000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	241845000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	7563000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	7612000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	54000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	109000	USD
CY2021Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1504000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	212000	USD
CY2021Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	4842000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	251049000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	228128000	USD
	us-gaap	Net Income Loss NetIncomeLoss	8924000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	4606000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	115000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	141000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	248000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2780000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	11052000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	228000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	228558000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	245021000	USD
	us-gaap	Net Income Loss NetIncomeLoss	15042000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1982000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	110000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	158000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	210000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2881000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	213000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	4842000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	251049000	USD
	us-gaap	Net Income Loss NetIncomeLoss	15042000	USD
	us-gaap	Net Income Loss NetIncomeLoss	8924000	USD
	cvcy	Decrease Deferred Loan Costs DecreaseDeferredLoanCosts	-1222000	USD
	cvcy	Decrease Deferred Loan Costs DecreaseDeferredLoanCosts	5975000	USD
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	467000	USD
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	462000	USD
	cvcy	Accretion Amortizationof Discountsand Premiums AccretionAmortizationofDiscountsandPremiums	693000	USD
	cvcy	Accretion Amortizationof Discountsand Premiums AccretionAmortizationofDiscountsandPremiums	666000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	3578000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2128000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	210000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	248000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-3300000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	4375000	USD
	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	-79000	USD
	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	4140000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	8000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	6000	USD
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	-112000	USD
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	183000	USD
	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	349000	USD
	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	198000	USD
	cvcy	Gain Loss On Bank Owned Life Insurance GainLossOnBankOwnedLifeInsurance	0	USD
	cvcy	Gain Loss On Bank Owned Life Insurance GainLossOnBankOwnedLifeInsurance	462000	USD
	cvcy	Increase Decrease In Accrued Interest Receivable And Other Operating Assets Net IncreaseDecreaseInAccruedInterestReceivableAndOtherOperatingAssetsNet	3767000	USD
	cvcy	Increase Decrease In Accrued Interest Receivable And Other Operating Assets Net IncreaseDecreaseInAccruedInterestReceivableAndOtherOperatingAssetsNet	1418000	USD
	cvcy	Increase Decrease In Interest Payable And Other Operating Liabilities Net IncreaseDecreaseInInterestPayableAndOtherOperatingLiabilitiesNet	14199000	USD
	cvcy	Increase Decrease In Interest Payable And Other Operating Liabilities Net IncreaseDecreaseInInterestPayableAndOtherOperatingLiabilitiesNet	417000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-983000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	1735000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	27775000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1771000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	271930000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	202390000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	590000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	122151000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	23660000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	16103000	USD
	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-32004000	USD
	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	176105000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	704000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	101000	USD
	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	10000000	USD
	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	250000	USD
	us-gaap	Payments For Proceeds From Federal Home Loan Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStock	0	USD
	us-gaap	Payments For Proceeds From Federal Home Loan Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStock	-467000	USD
	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	0	USD
	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	1550000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	9000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	6000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-226371000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-238569000	USD
	cvcy	Net Increase Decrease In Demand Interest Bearing And Savings Deposits NetIncreaseDecreaseInDemandInterestBearingAndSavingsDeposits	256426000	USD
	cvcy	Net Increase Decrease In Demand Interest Bearing And Savings Deposits NetIncreaseDecreaseInDemandInterestBearingAndSavingsDeposits	319263000	USD
	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	-42000	USD
	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	-2993000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4842000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11052000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	110000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	115000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	213000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	228000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2881000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2780000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	248984000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	302781000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	50388000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	65983000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	70278000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52574000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	120666000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118557000	USD
	us-gaap	Interest Paid Net InterestPaidNet	576000	USD
	us-gaap	Interest Paid Net InterestPaidNet	937000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6105000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2810000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	1124000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	1120000	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	No customer accounts for more than 10 percent of revenues for the Company or the Bank.
CY2021Q2	us-gaap	Pledged Assets Separately Reported Securities Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedSecuritiesPledgedAsCollateralAtFairValue	191882000	USD
CY2021Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	18278000	USD
CY2020Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	21091000	USD
CY2021Q2	cvcy	Accumulated Other Comprehensive Income Available For Sale Securities Adjustment Tax AccumulatedOtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentTax	5404000000	USD
CY2020Q4	cvcy	Accumulated Other Comprehensive Income Available For Sale Securities Adjustment Tax AccumulatedOtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentTax	6235000	USD
CY2021Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	934138000	USD
CY2021Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	22780000	USD
CY2021Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4502000	USD
CY2021Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	952416000	USD
CY2020Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	689001000	USD
CY2020Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	23371000	USD
CY2020Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2280000	USD
CY2020Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	710092000	USD
CY2021Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	4037000	USD
CY2021Q2	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	590000	USD
CY2020Q2	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	16114000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	590000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	122151000	USD
CY2021Q2	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0	USD
CY2020Q2	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	306000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	4504000	USD
CY2021Q2	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	79000	USD
CY2020Q2	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	364000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	79000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	364000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	1224000	USD
CY2021Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	245156000	USD
CY2021Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	57021000	USD
CY2021Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	465000	USD
CY2021Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	302177000	USD
CY2021Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	4502000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	105252000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1085000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	81237000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	1195000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	186489000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	2280000	USD
	cvcy	Threshold Period Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment ThresholdPeriodOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment	P12M
	cvcy	Threshold Percentage Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment ThresholdPercentageOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment	0.10
	cvcy	Threshold Amount Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment ThresholdAmountOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment	75000	USD
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2021Q2	cvcy	Available For Sale Securities Number Of Securities Loss Position AvailableForSaleSecuritiesNumberOfSecuritiesLossPosition	5	Loans
CY2021Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	304000	USD
CY2021Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	305000	USD
CY2021Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	3317000	USD
CY2021Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	3627000	USD
CY2021Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	84162000	USD
CY2021Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	86564000	USD
CY2021Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	390454000	USD
CY2021Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	403156000	USD
CY2021Q2	cvcy	Available For Sale Securities Debt Maturities With Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesWithSingleMaturityDateAmortizedCostBasis	478237000	USD
CY2021Q2	cvcy	Available For Sale Securities Debt Maturities With Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithSingleMaturityDateFairValue	493652000	USD
CY2021Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	934138000	USD
CY2021Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	952416000	USD
CY2021Q2	us-gaap	Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums	-1390000	USD
CY2020Q4	us-gaap	Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums	-2612000	USD
CY2021Q2	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1069945000	USD
CY2021Q2	cvcy	Loans And Leases Receivable Percentage Of Gross Loans LoansAndLeasesReceivablePercentageOfGrossLoans	1.000
CY2020Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1102347000	USD
CY2020Q4	cvcy	Loans And Leases Receivable Percentage Of Gross Loans LoansAndLeasesReceivablePercentageOfGrossLoans	1.000
CY2021Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	10439000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	12915000	USD
CY2021Q2	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1059506000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1089432000	USD
CY2021Q2	cvcy	Loansand Leases Receivable Allowance Numberof Components LoansandLeasesReceivableAllowanceNumberofComponents	2	component
CY2021Q2	cvcy	Financing Receivable Allowance For Credit Losses Methodology Change Number Of Rolling Quarters Used In Analysis FinancingReceivableAllowanceForCreditLossesMethodologyChangeNumberOfRollingQuartersUsedInAnalysis	50	quarter
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12056000	USD
CY2021Q2	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	1500000	USD
CY2021Q2	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	171000	USD
CY2021Q2	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	54000	USD
CY2021Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10439000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10546000	USD
CY2020Q2	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	3000000	USD
CY2020Q2	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	80000	USD
CY2020Q2	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	471000	USD
CY2020Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13937000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12915000	USD
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	3300000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	228000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	1052000	USD
CY2021Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10439000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9130000	USD
	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-4375000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	123000	USD
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	555000	USD
CY2020Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13937000	USD
CY2021Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10439000	USD
CY2021Q2	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	880000	USD
CY2021Q2	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	9559000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12915000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	631000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	12284000	USD
CY2021Q2	us-gaap	Notes Receivable Gross NotesReceivableGross	1071335000	USD
CY2021Q2	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	8539000	USD
CY2021Q2	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1062796000	USD
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1104959000	USD
CY2020Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	11186000	USD
CY2020Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1093773000	USD
CY2021Q2	us-gaap	Notes Receivable Gross NotesReceivableGross	1071335000	USD
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1104959000	USD
CY2021Q2	us-gaap	Notes Receivable Gross NotesReceivableGross	1071335000	USD
CY2021Q2	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2021Q2	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	2035000	USD
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1104959000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	3278000	USD
CY2021Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	939000	USD
CY2021Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	1036000	USD
CY2021Q2	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	7600000	USD
CY2021Q2	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	7674000	USD
CY2021Q2	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	880000	USD
CY2021Q2	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	8539000	USD
CY2021Q2	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	8710000	USD
CY2021Q2	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	880000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	1114000	USD
CY2021Q2	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	34000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	1239000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	10072000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	10132000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	631000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	11186000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	11371000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	631000	USD
CY2021Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	965000	USD
CY2021Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	8000	USD
CY2020Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	1899000	USD
CY2020Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	3000	USD
CY2021Q2	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	9007000	USD
CY2021Q2	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	84000	USD
CY2020Q2	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	13584000	USD
CY2020Q2	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	200000	USD
	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	74000	USD
CY2021Q2	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	9972000	USD
CY2021Q2	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	92000	USD
CY2020Q2	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	15483000	USD
CY2020Q2	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	203000	USD
	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	953000	USD
	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	17000	USD
	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	2050000	USD
	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	6000	USD
	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	9652000	USD
	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	186000	USD
	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	8353000	USD
	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	402000	USD
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	10605000	USD
	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	203000	USD
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	10403000	USD
	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	408000	USD
	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	72000	USD
	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
CY2020Q3	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	55000	USD
CY2021Q2	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	6504000	USD
CY2020Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	7908000	USD
CY2021Q2	cvcy	Financing Receivable Modifications Related Allowance FinancingReceivableModificationsRelatedAllowance	515000	USD
CY2020Q4	cvcy	Financing Receivable Modifications Related Allowance FinancingReceivableModificationsRelatedAllowance	20000	USD
CY2021Q2	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	1	Loans
CY2021Q2	us-gaap	Goodwill Goodwill	53777000	USD
CY2020Q4	us-gaap	Federal Funds Purchased FederalFundsPurchased	0	USD
CY2021Q2	us-gaap	Federal Funds Purchased FederalFundsPurchased	0	USD
CY2021Q2	us-gaap	Other Commitment OtherCommitment	2475000	USD
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7563000	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2301000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	15042000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8924000	USD
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12498809	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12449283	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12497217	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12592126	shares
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.61
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.71
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7563000	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2301000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	15042000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8924000	USD
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12498809	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12449283	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12497217	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12592126	shares
CY2021Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	49235	shares
CY2020Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	37398	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	50884	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	54277	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12548044	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12486681	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12548101	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12646403	shares
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.60
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2021Q2	cvcy	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Plans SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPlans	4	plan
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	210000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	248000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	77070	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.06
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	20000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.63
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	57070	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.86
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y21D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	587000	USD
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	57070	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	9.86
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P1Y21D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	587000	USD
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	57070	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	9.86
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P1Y21D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	587000	USD
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	204000	USD
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	32000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	206000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	381000	USD
CY2021Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	212000	USD
CY2020Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	19000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	213000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	228000	USD
CY2021Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	46000	USD
CY2020Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	0	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	46000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	72000	USD
CY2021Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	USD
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.61
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.60
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2021Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-1500000	USD
CY2020Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	3000000	USD
CY2021Q2	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	13556000	USD
CY2020Q2	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	12600000	USD
CY2021Q2	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	252000	USD
CY2020Q2	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	374000	USD
CY2021Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-1500000	USD
CY2020Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	3000000	USD
CY2021Q2	cvcy	Service Charges ServiceCharges	467000	USD
CY2020Q2	cvcy	Service Charges ServiceCharges	447000	USD
CY2021Q2	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	449000	USD
CY2020Q2	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	537000	USD
CY2021Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6979000	USD
CY2020Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6812000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2465000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	820000	USD

Files In Submission

Name	View Source	Status
0001127371-21-000128-index-headers.html	Edgar Link	pending
0001127371-21-000128-index.html	Edgar Link	pending
0001127371-21-000128.txt	Edgar Link	pending
0001127371-21-000128-xbrl.zip	Edgar Link	pending
cvcy-20210630.htm	Edgar Link	pending
cvcy-20210630.xsd	Edgar Link	pending
cvcy-20210630_cal.xml	Edgar Link	unprocessable
cvcy-20210630_def.xml	Edgar Link	unprocessable
cvcy-20210630_htm.xml	Edgar Link	completed
cvcy-20210630_lab.xml	Edgar Link	unprocessable
cvcy-20210630_pre.xml	Edgar Link	unprocessable
exhibit1093salarycontinuat.htm	Edgar Link	pending
exhibit1094splitdollarluis.htm	Edgar Link	pending
exhibit3112021q2-ng.htm	Edgar Link	pending
exhibit3122021q2-ng.htm	Edgar Link	pending
exhibit3212021q2-ng.htm	Edgar Link	pending
exhibit3222021q2-ng.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CWBC
Community West Bancshares Stock $cwbc

2021 Q2 Form 10-Q Financial Statement

#000112737121000128 Filed on August 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBC Community West Bancshares Stock $cwbc

2021 Q2 Form 10-Q Financial Statement

#000112737121000128 Filed on August 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBC
Community West Bancshares Stock $cwbc